554 related articles for article (PubMed ID: 25563493)
21. Clinical significance of Gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance.
Sato M; Kawana K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Adachi K; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Oncol Rep; 2016 Jan; 35(1):391-7. PubMed ID: 26530461
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
23. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
Islam F; Gopalan V; Smith RA; Lam AK
Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer stem cells: The root of resistance.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
[TBL] [Abstract][Full Text] [Related]
25. Lung cancer stem cells and implications for future therapeutics.
Wang J; Li ZH; White J; Zhang LB
Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
27. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
28. Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes.
Jia Y; Chen J; Zhu H; Jia ZH; Cui MH
Oncol Rep; 2015 Nov; 34(5):2296-304. PubMed ID: 26324021
[TBL] [Abstract][Full Text] [Related]
29. Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
Naik PP; Das DN; Panda PK; Mukhopadhyay S; Sinha N; Praharaj PP; Agarwal R; Bhutia SK
Oral Oncol; 2016 Nov; 62():122-135. PubMed ID: 27865365
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.
Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL
Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498
[TBL] [Abstract][Full Text] [Related]
32. Tumor dormancy and cancer stem cells: two sides of the same coin?
Kleffel S; Schatton T
Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
[TBL] [Abstract][Full Text] [Related]
33. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
34. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.
Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W
Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective.
Koch U; Krause M; Baumann M
Semin Cancer Biol; 2010 Apr; 20(2):116-24. PubMed ID: 20219680
[TBL] [Abstract][Full Text] [Related]
36. CD90 a potential cancer stem cell marker and a therapeutic target.
Shaikh MV; Kala M; Nivsarkar M
Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
[TBL] [Abstract][Full Text] [Related]
37. The clinical and therapeutic implications of cancer stem cell biology.
Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Ahmed N; Abubaker K; Findlay JK
Mol Aspects Med; 2014 Oct; 39():110-25. PubMed ID: 23811037
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - An updated review.
Muinao T; Deka Boruah HP; Pal M
Exp Cell Res; 2018 Jan; 362(1):1-10. PubMed ID: 29079264
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells: A brief review of the current status.
Kuşoğlu A; Biray Avcı Ç
Gene; 2019 Jan; 681():80-85. PubMed ID: 30268439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
